Serum Folate Levels and Risk of Metabolic Dysfunction-associated Steatotic Liver Disease: Results from a Cross-sectional Study and Mendelian Randomization Analysis

Overview

Journal Front Nutr

Specialty Nutritional Sciences

Date 2024 Sep 19

PMID 39296498

Authors

Yalan Chen

Jie Gao

Xibin Wang

Hong Lu

Ya Zheng

Qian Ren

Affiliations

Soon will be listed here.

Abstract

Background: Evidence from observational studies on the association between folate and metabolic dysfunction-associated steatotic liver disease (MASLD) is conflicting.

Aims: This study aimed to investigate the association between serum folate concentration and MASLD and further assess the causal relationship using Mendelian randomization (MR) analysis.

Methods: To investigate the causal relationship between serum folate and MASLD, we conducted a cross-sectional study that selected 1,117 participants from the 2017-2020 National Health and Nutrition Examination Survey (NHANES). The association between serum folate level and the risk of MASLD was evaluated under a multivariate logistic regression model. In addition, we conducted a two-sample MR study using genetic data from a large genome-wide association study (GWAS) to compare serum folate level (37,465 individuals) and MASLD (primary analysis: 8,434 cases/770,180 controls; Secondary analysis:1,483 cases/17,781 controls) were performed to infer causal relationships between them. Inverse variance weighted (IVW) was used as the primary method of MR Analysis.

Results: The results from the NHANES database showed that Tertile 3 group (Tertile 3: ≥ 48.6 nmol/L) had a significantly lower risk (OR = 0.58, 95% CI: 0.38-0.88, = 0.010) of MASLD than Tertile 1 group (Tertile 1: < 22.3 nmol/L) after complete adjustments. However, in the IVW of MR analysis, there was no causal relationship between serum folate level and MASLD risk in the primary analysis (OR = 0.75, 95% CI: 0.55-1.02, = 0.065) and secondary analysis (OR = 0.83, 95% CI: 0.39-1.74, = 0.618).

Conclusion: In observational analyses, we observed an inverse association between higher serum folate concentrations and a reduced risk of MASLD. Our MR study generated similar results, but the association failed to reach the significance threshold of < 0.05, suggesting that our MR study does not support a causal relationship between serum folate levels and MASLD risk. Additional research involving a larger number of cases would contribute to enhancing the confirmation of our preliminary findings.

Citing Articles

The moderating effect of dietary fiber intake on the association between sleep pattern and liver fibrosis in metabolic dysfunction-associated steatotic liver disease: a study from NHANES.

Jia G, Jia M, Li C BMC Gastroenterol. 2024; 24(1):457.

PMID: 39695427 PMC: 11654364. DOI: 10.1186/s12876-024-03538-8.

References

Mendez-Sanchez N, Cruz-Ramon V, Ramirez-Perez O, Hwang J, Barranco-Fragoso B, Cordova-Gallardo J . New Aspects of Lipotoxicity in Nonalcoholic Steatohepatitis. Int J Mol Sci. 2018; 19(7). PMC: 6073816. DOI: 10.3390/ijms19072034. View

Ghodsian N, Abner E, Emdin C, Gobeil E, Taba N, Haas M . Electronic health record-based genome-wide meta-analysis provides insights on the genetic architecture of non-alcoholic fatty liver disease. Cell Rep Med. 2021; 2(11):100437. PMC: 8606899. DOI: 10.1016/j.xcrm.2021.100437. View

Fairfield C, Drake T, Pius R, Bretherick A, Campbell A, Clark D . Genome-Wide Association Study of NAFLD Using Electronic Health Records. Hepatol Commun. 2021; 6(2):297-308. PMC: 8793997. DOI: 10.1002/hep4.1805. View

Liu X, Shen H, Chen M, Shao J . Clinical Relevance of Vitamins and Carotenoids With Liver Steatosis and Fibrosis Detected by Transient Elastography in Adults. Front Nutr. 2021; 8:760985. PMC: 8632634. DOI: 10.3389/fnut.2021.760985. View

Zhang L, Sun J, Li Z, Zhang D . The relationship between serum folate and grip strength in American adults. Arch Osteoporos. 2021; 16(1):97. DOI: 10.1007/s11657-021-00937-2. View

Liu Y, Shen J, Yang X, Sun Q, Yang X . Folic Acid Reduced Triglycerides Deposition in Primary Chicken Hepatocytes. J Agric Food Chem. 2018; 66(50):13162-13172. DOI: 10.1021/acs.jafc.8b05193. View

Yang S, Ye Z, Liu M, Zhang Y, Wu Q, Zhou C . Associations of different serum folate forms with indices of nonalcoholic fatty liver disease and advanced fibrosis. Obes Res Clin Pract. 2023; 17(1):58-65. DOI: 10.1016/j.orcp.2023.01.004. View

Meir A, Rinott E, Tsaban G, Zelicha H, Kaplan A, Rosen P . Effect of green-Mediterranean diet on intrahepatic fat: the DIRECT PLUS randomised controlled trial. Gut. 2021; 70(11):2085-2095. PMC: 8515100. DOI: 10.1136/gutjnl-2020-323106. View

Sekula P, Del Greco M F, Pattaro C, Kottgen A . Mendelian Randomization as an Approach to Assess Causality Using Observational Data. J Am Soc Nephrol. 2016; 27(11):3253-3265. PMC: 5084898. DOI: 10.1681/ASN.2016010098. View

10.

Yuan S, Chen J, Dan L, Xie Y, Sun Y, Li X . Homocysteine, folate, and nonalcoholic fatty liver disease: a systematic review with meta-analysis and Mendelian randomization investigation. Am J Clin Nutr. 2022; 116(6):1595-1609. DOI: 10.1093/ajcn/nqac285. View

11.

. EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease. Diabetologia. 2016; 59(6):1121-40. DOI: 10.1007/s00125-016-3902-y. View

12.

Kolb A, Petrie L . Folate deficiency enhances the inflammatory response of macrophages. Mol Immunol. 2013; 54(2):164-72. DOI: 10.1016/j.molimm.2012.11.012. View

13.

Bjornsson E, Thorleifsson G, Helgadottir A, Gudnason T, Gudbjartsson T, Andersen K . Association of Genetically Predicted Lipid Levels With the Extent of Coronary Atherosclerosis in Icelandic Adults. JAMA Cardiol. 2019; 5(1):13-20. PMC: 6902100. DOI: 10.1001/jamacardio.2019.2946. View

14.

Kim H, Min H . Folic acid supplementation prevents high fructose-induced non-alcoholic fatty liver disease by activating the AMPK and LKB1 signaling pathways. Nutr Res Pract. 2020; 14(4):309-321. PMC: 7390741. DOI: 10.4162/nrp.2020.14.4.309. View

15.

Ahluwalia N, Dwyer J, Terry A, Moshfegh A, Johnson C . Update on NHANES Dietary Data: Focus on Collection, Release, Analytical Considerations, and Uses to Inform Public Policy. Adv Nutr. 2016; 7(1):121-34. PMC: 4717880. DOI: 10.3945/an.115.009258. View

16.

Le M, Yeo Y, Li X, Li J, Zou B, Wu Y . 2019 Global NAFLD Prevalence: A Systematic Review and Meta-analysis. Clin Gastroenterol Hepatol. 2021; 20(12):2809-2817.e28. DOI: 10.1016/j.cgh.2021.12.002. View

17.

Sid V, Siow Y, O K . Role of folate in nonalcoholic fatty liver disease. Can J Physiol Pharmacol. 2017; 95(10):1141-1148. DOI: 10.1139/cjpp-2016-0681. View

18.

Masarone M, Federico A, Abenavoli L, Loguercio C, Persico M . Non alcoholic fatty liver: epidemiology and natural history. Rev Recent Clin Trials. 2014; 9(3):126-33. DOI: 10.2174/1574887109666141216111143. View

19.

Li L, Fu J, Liu D, Sun J, Hou Y, Chen C . Hepatocyte-specific Nrf2 deficiency mitigates high-fat diet-induced hepatic steatosis: Involvement of reduced PPARγ expression. Redox Biol. 2020; 30:101412. PMC: 6940621. DOI: 10.1016/j.redox.2019.101412. View

20.

Rives C, Fougerat A, Ellero-Simatos S, Loiseau N, Guillou H, Gamet-Payrastre L . Oxidative Stress in NAFLD: Role of Nutrients and Food Contaminants. Biomolecules. 2020; 10(12). PMC: 7767499. DOI: 10.3390/biom10121702. View